Author

D. Anand

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cancer Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Approach:genetic perturbation / CRISPR· 2 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Assay:ChIP-seq· 1 Research Focus:chromatin & epigenetic regulation· 1

Frequent Co-Authors

A. Bhattacharjee· 1 shared A. Miskalis· 1 shared A. Pradhan· 1 shared A. Soshnev· 1 shared A. V. Krivtsov· 1 shared C. D. Allis· 1 shared C. K. W. Lim· 1 shared D. Cheon· 1 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 13 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

A. Bhattacharjee

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

In vivo CRISPR base editing for treatment of Huntington's disease

S. Shirguppe, M. Gapinske, D. Swami, N. Gosstola, P. Acharya, A. Miskalis, D. Joulani, M. G. Szkwarek, A. Bhattacharjee, G. Elias, M. Stilger, J. Winter, W. S. Woods, D. Anand, C. K. W. Lim, , P. Perez-Pinera

This study uses CRISPR base editing to create HTT protein isoforms resistant to caspase-6 cleavage, reducing toxicity and neurodegeneration in a rodent HD model.

bioRxiv · Jul 5, 2024Bioengineering

Complete identity of the cis-asRNA StfZ and its influence on FtsZ protein level and cell division in Escherichia coli

D. Anand, K. Jakkala, R. R. Nair, D. Sharan, A. Pradhan, N. Mukkayyan, P. Ajitkumar

The paper identifies the complete sequence and promoters of the cis-antisense RNA StfZ in E. coli and shows it regulates FtsZ protein levels and cell division.

bioRxiv · Mar 8, 2022 · PreprintMicrobiology

A molecular switch between mammalian MLL complexes dictates response to Menin-MLL inhibition

Y. M. Soto-Feliciano, F. J. Sanchez-Rivera, F. Perner, D. W. Barrows, E. R. Kastenhuber, Y.-J. Ho, T. Carroll, Y. Xiong, D. Anand, A. Soshnev, L. Gates, M. C. Beytagh, D. Cheon, S. Gu, X. S. Liu, , C. D. Allis

The paper identifies a molecular switch between MLL1-Menin and MLL3/4-UTX complexes that determines response to Menin-MLL inhibitors in leukemia.

bioRxiv · Oct 22, 2021Cancer Biology